Orthofix Medical Inc. (OFIX)
Orthofix Medical Inc. (OFIX) Stock Price, Analysis & Data
| Bid | 7.44 |
| Market Cap | 411.29M |
| Revenue (ttm) | 833.19M |
| Net Income (ttm) | -61.72M |
| Beta | 0.67 |
| EPS (ttm) | -1.52 |
| PE Ratio (ttm) | n/a |
| Forward PE | 27.5 |
| P/B (ttm) | 0.97 |
| P/S (ttm) | 0.50 |
| Earnings Date | Nov 3, 2026 |
| Ask | 12.78 |
| Volume | 86,923 |
| Avg. Volume (20D) | 439,453 |
| Open | 10.32 |
| Previous Close | 10.32 |
| Day's Range | 9.96 - 10.32 |
| 52-Week Range | 8.85 - 16.99 |
| Analyst | Buy |
| Price Target | 13 (27.70%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About OFIX
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a por...
Financial Performance
In 2025, Orthofix Medical's revenue was 822.31M, an increase of 2.85% compared to the previous year's 799.49M. Earnings were -92.19M, a decrease of -26.83%.
Financial StatementsAnalyst Forecast
According to 4 analyst ratings, the average rating for OFIX stock is "Buy". The 12-month stock price forecast is 13, which is upside of 27.7% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
